White paperThe Enterprise Framework for Compliant, Scalable AI
Download now

Data & Infrastructure

Scalable Data Infrastructure for Life Sciences

Life sciences organizations still struggle with disconnected systems and manual workarounds. Fixing those two problems alone still won't equate to effectively scaling. Strong data infrastructure creates the foundation for trusted reporting, compliant workflow automation, connected operations, and better executive decision-making. By improving data integrity, integration, interoperability, and analytics, organizations can reduce risk, increase visibility, and build a more inspection-ready digital environment that supports both operational performance and long-term transformation.

Contact USDM Explore details

Data Integrity in Life Sciences

Data Integrity in Life Sciences

Data integrity in life sciences is the foundation for compliant operations, trusted decisions, and scalable digital transformation. When data is fragmented or managed across disconnected systems, the risk of errors, delays, and regulatory exposure increases. USDM helps organizations strengthen traceability, support GxP compliance, and build the trusted data foundation needed for analytics, automation, and AI in regulated environments.

Read the Blog Read the Case Study

Data Integration & Interoperability

Enterprise Data Integration & Interoperability for Life Sciences

Data integration and interoperability in life sciences connect fragmented systems so regulated data can move with greater accuracy, speed, and control. Through compliant integration strategies, USDM unifies quality, clinical, regulatory, and operational data to reduce manual handoffs, improve visibility, and support automation, analytics, and AI. The result is a more connected, scalable, and inspection-ready digital foundation for regulated growth.

Read the Blog Read the Case Study Read the Case Study

Compliant Workflow Automation

Compliant Workflow Automation for Life Sciences

Compliant workflow automation helps life sciences organizations reduce manual effort while maintaining control over regulated processes. When automation is designed without compliance in mind, it can create gaps in traceability, oversight, and change management. USDM brings the life sciences and compliance expertise needed to design workflow automation that improves efficiency, supports GxP requirements, and creates more reliable, scalable processes across quality, regulatory, and operational environments.

Read the Case Study Explore ProcessX

Business Intelligence & Analytics

Regulated Business Intelligence & Analytics for Life Sciences

Business intelligence and analytics in life sciences transform fragmented data into clearer, faster decision support for regulated teams. When reporting environments lack structure and trust, visibility suffers and execution slows. With deep life sciences expertise, USDM builds compliant analytics foundations that improve insight across quality, regulatory, clinical, and operational functions, giving organizations stronger governance, better performance visibility, and more confidence in the decisions they make.

Read the Case Study Download the White Paper

Data foundation layer

Data is the foundation layer for domain AI.

In life sciences, the data layer has to preserve context, permissions, lineage, and evidence so agents and workflows can support regulated work without creating new risk.

Connect to AI deployment See people + adoption
Data foundation layerLife sciences workflow stack
Source systems
QualityRegulatoryClinicalManufacturingCommercial
Governed data foundation

Lineage

Traceable records

Access

Right context, right people

Governance

Reviewable controls

Agent / workflow layer

What it does

Retrieve, draft, route, summarize, and capture evidence inside regulated work.

Human control

Qualified review stays explicit where decisions need it.

Measurable business outcomes

Faster cycle times

Cleaner handoffs

Inspectable evidence

Built for Quality, Regulatory, Clinical, Manufacturing, and Commercial teams

Deep dives

Go deeper on the topics that matter most.

Explore detailed briefs on high-priority regulatory, compliance, and AI topics — each connecting USDM expertise to the specific challenges your organization faces.

Business Intelligence & Analytics for Life Sciences: Turning Regulated Data into Better Decisions

Discover how business intelligence and analytics help life sciences organizations improve compliance, accelerate insight, and drive smarter decisions across clinical, quality, regulatory, and commercial operations.

Read now

Compliant Workflow Automation in Life Sciences: How to Move Faster Without Losing Control

Learn how compliant workflow automation helps life sciences companies reduce manual effort, improve traceability, and scale regulated operations without compromising GxP compliance.

Read now

Data Integration & Interoperability in Life Sciences: How to Build a Connected, Compliant Data Ecosystem

Learn why data integration and interoperability are critical in life sciences, and how connected, standards-aligned data improves compliance, speed, visibility, and AI readiness.

Read now

Data Integrity in Life Sciences: Best Practices for Compliance, Quality, and AI Readiness

Learn why data integrity in life sciences matters for compliance, quality, and AI readiness, and explore best practices for governance, automation, and secure digital records.

Read now

Explore

Proof and guidance across this practice area

Case studies, blogs, webinars, and guides connected to this capability.

Blog

Evaluating Google Agentspace for Life Sciences

A practical 10-factor framework for life sciences teams evaluating Google Agentspace—covering GxP compliance, data security, auditability, multi-agent governance, and ROI for confident, validated AI adoption.

Read
GovernanceContinuous compliance

Optimized Use of TraceLink Helps Pharma Company Implement Serialization

Specialty pharmaceutical company focused on autoimmune disease therapies, with no prior serialization experience and no in-house TraceLink expertise.

Case study on Optimized Use of TraceLink Helps Pharma Company Implement Serialization.

Delivery

On Time, Under Budget

See proof
GovernanceContinuous compliance

Box Meets Complex Security and Global GxP Validation Requirements

Global biosciences company founded in China with U.S. locations, developing infectious disease treatments (including COVID-19) and in Stage II clinical trials, with limited in-house computer system validation and GxP regulatory experience.

Discover how USDM enabled FDA-ready Box GxP validation for a global biosciences company, meeting tight deadlines and complex security requirements.

Global CSV Outcome

Defensible

See proof
White Paper

2023 Technology Trends in Life Sciences

Explore five technology trends—automation, data collaboration platforms, cloud landing zones, AR/VR, and IoT—that help pharma, biotech, and medical device companies modernize while staying compliant. Download the white paper.

Read
AI deploymentGovernance

Daily Monitoring Enables Immediate Action for Security Issues and Continuous Compliance

Clinical-stage pharmaceutical company running clinical trials under global regulatory oversight, using a Clinical Data Management System (CDMS) with admin-level / Vault Owner access controls.

Learn how using a CDMS audit trail supported daily security monitoring, helped detect critical issues, and enabled swift resolutions.

Detection-to-Action Window

Within 24 hours

See proof
White Paper

2022 Trends in Life Sciences

A USDM white paper on the 2022 trends reshaping life sciences — from Computer Software Assurance and AI-infused GxP process automation to data-driven decision intelligence and a better employee experience.

Read

Frequently Asked Questions

Questions leaders ask before they move.

Why is data infrastructure a strategic issue in life sciences?

Data infrastructure has become a strategic priority because growth, compliance, and digital transformation all depend on trusted data. In many life sciences organizations, critical information still sits across disconnected systems, manual workflows, and inconsistent reporting environments. That fragmentation slows decisions, limits visibility, and creates risk. Strong data infrastructure gives leadership a more reliable foundation for governance, operational control, and scalable innovation.

Why does data integrity matter at the executive level?

Data integrity is not just a quality or compliance issue. It is an executive issue because business decisions are only as strong as the data behind them. When data is fragmented, moved manually, or managed inconsistently, organizations increase exposure to errors, delays, and regulatory scrutiny. A stronger data integrity foundation improves trust in reporting, supports inspection readiness, and enables more confident decision-making across the enterprise.

How do data integration and interoperability improve business performance?

Data integration and interoperability improve business performance by connecting systems that drive core regulated operations. When data can move accurately across quality, regulatory, clinical, and operational environments, organizations reduce manual effort and gain better visibility into performance. For leadership teams, that means fewer silos, faster access to insight, and a more connected operating model that supports both compliance and execution.

Why is compliant workflow automation important for infrastructure strategy?

Compliant workflow automation is important because automation without control often creates new risk instead of reducing it. In regulated environments, automated processes must still support traceability, oversight, and change management. A sound infrastructure strategy treats automation as part of the broader operating model, ensuring efficiency gains are matched by stronger process reliability, regulatory alignment, and scale.

How do business intelligence and analytics depend on data infrastructure?

Business intelligence and analytics are only as effective as the infrastructure underneath them. If data sources are disconnected or inconsistent, reporting becomes harder to trust and slower to use. A stronger data infrastructure foundation improves the quality, availability, and usability of enterprise data, allowing leadership teams to make faster decisions with better visibility into performance, risk, and operational trends.

What should executives expect from a modern life sciences data infrastructure strategy?

A modern data infrastructure strategy should do more than connect systems. It should improve data integrity, support compliant workflow automation, enable stronger business intelligence and analytics, and reduce the operational drag created by fragmented environments. For life sciences organizations, the objective is clear: create a scalable, inspection-ready foundation that supports better decisions, stronger governance, and long-term digital growth.